De Novo Psoriasis Vulgaris Diagnosed after Nivolumab Treatment for Refractory Hodgkin's Lymphoma, Completely Resolved after Autologous Hematopoietic Stem Cell Transplantation

The programmed cell death protein-1 (PD-1) inhibitor nivolumab has been recently approved as an effective and safe treatment for patients with refractory/relapsed Hodgkin's lymphomas. Dermatological adverse events, mainly skin rash, have been reported in 1–5% of patients. We describe a case of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Hematol
Main Authors: Kaloyannidis, Panayotis, Al Shaibani, Eshrak, Mashhour, Miral, Gamil, Mohammed, Apostolidis, Ioannis, Al Hashmi, Hani, Al Anazi, Khalid Ahmed
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2018
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206568/
https://ncbi.nlm.nih.gov/pubmed/30410803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/6215958
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados